Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Three Stocks To Watch Friday Afternoon 3/18/2016

MIAMI, FL / ACCESSWIRE / March 18, 2016 / Top Nasdaq Stocks is issuing a report on three stocks to watch. NWY, ONTY, and TBIO have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.

New York & Company, Inc. (NYSE: NWY) is a professional clothing retailer for women. The attire is distributed through a countrywide network of retail shops, New York & Company Outlet Stores and through its website. NWY released its Q4 2015 results this week. As of the 17th, the stock price has climbed 32% in the month of March, with a maximum daily return of 18.5% on March 1st. In addition, during the first trading week of March, the stock's price rose at a 15% clip, and climbed 9.05% in the following week.

Stay Informed and Up To Date On The Hottest NASDAQ Plays Like NWY Before They Break Out. Get Them Here.

Oncothyreon, Inc. (USA) (NASDAQ: ONTY) has had its stock price rise at a rate of 19.94% since the month of March began. During that same time period, the stock reached highs of $1.275 and delivered a daily return of 8.41%. Oncothyreon, Inc. is a biotechnology company focused on developing oncology products that can better the lives and results of cancer patients. The company is devoted to creating cancer treatments that minimizes damage to the cancer's surrounding healthy tissue.

Members of record by 4PM March 18 will secure a place-holder to receive our next report. Get Your Free Membership Now.

Transgenomic, Inc. (NASDAQ: TBIO) is a biotechnology company furthering tailored medicine in oncology, cardiology, neurology, and genetic conditions through advanced diagnostic technologies, products and services. Since March 1st, the stock has increased 23.21% with return potential of 12.70% on March 7th. Furthermore, the stock's volume has ascended 49.64% from 17,969 shares to 26,889 shares thus far during the month.

Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948

About TopNasdaqStocks.com

Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.

Contact:

Top Nasdaq Stocks
news@topnasdaqstocks.com

SOURCE: Top Nasdaq Stocks



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today